These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7536388)

  • 1. Erythromycin-induced cardiac toxicity.
    Orban Z; MacDonald LL; Peters MA; Guslits B
    Am J Cardiol; 1995 Apr; 75(12):859-61. PubMed ID: 7536388
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia.
    de Koning J; van der Hoeven H; Hamer B; Thompson J
    Neth J Med; 1994 Apr; 44(4):131-5. PubMed ID: 8196823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
    Brandriss MW; Richardson WS; Barold SS
    Clin Infect Dis; 1994 Jun; 18(6):995-8. PubMed ID: 8086567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Access of torsades de pointes in Legionnaires' disease: an uncommon adverse effect of erythromycin].
    Staikowsky F; Haziza F; Guidet B; Vassal T; Offenstadt G
    Rev Pneumol Clin; 1991; 47(2):92-4. PubMed ID: 1759106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe ventricular arrhythmia secondary to indapamide-induced hypopotassemia].
    Guzzini F; Baroffio R; Coppetti D; Gasparini P
    Clin Ter; 1990 Nov; 135(4):283-7. PubMed ID: 1705875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin induced torsades de pointes.
    Wong CB; Windle J
    Nebr Med J; 1995 Sep; 80(9):285-6. PubMed ID: 7566254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration.
    Koh TW
    Pacing Clin Electrophysiol; 2001 Oct; 24(10):1575-6. PubMed ID: 11707056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes induced by erythromycin.
    Gitler B; Berger LS; Buffa SD
    Chest; 1994 Feb; 105(2):368-72. PubMed ID: 8306730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
    Lengyel C; Várkonyi T; Fazekas T
    Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aconite poisoning managed with a ventricular assist device.
    Fitzpatrick AJ; Crawford M; Allan RM; Wolfenden H
    Anaesth Intensive Care; 1994 Dec; 22(6):714-7. PubMed ID: 7892979
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin.
    Biglin KE; Faraon MS; Constance TD; Lieh-Lai M
    Ann Pharmacother; 1994 Feb; 28(2):282. PubMed ID: 8173153
    [No Abstract]   [Full Text] [Related]  

  • 15. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors.
    Bertino JS; Owens RC; Carnes TD; Iannini PB
    Clin Infect Dis; 2002 Mar; 34(6):861-3. PubMed ID: 11830802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ventricular arrhythmia following thioridazine poisoning].
    Quieffin J; Brochet E; Gamerman G; Assayag P; Antony I; Valère PE
    Ann Cardiol Angeiol (Paris); 1991 Apr; 40(4):199-201. PubMed ID: 2053762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsades de pointes induced by erythromycin and terfenadine.
    Paris DG; Parente TF; Bruschetta HR; Guzman E; Niarchos AP
    Am J Emerg Med; 1994 Nov; 12(6):636-8. PubMed ID: 7945604
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polymorph ventricular tachycardia with torsades de pointes caused by administration of terodiline (Mictrol)].
    van der Klauw MM; van Rey FJ; Stricker BH
    Ned Tijdschr Geneeskd; 1992 Jan; 136(2):91-3. PubMed ID: 1370730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.